Your browser doesn't support javascript.
loading
Establishment and Characterization of PCL12, a Novel CD5+ Chronic Lymphocytic Leukaemia Cell Line.
Agathangelidis, Andreas; Scarfò, Lydia; Barbaglio, Federica; Apollonio, Benedetta; Bertilaccio, Maria Teresa Sabrina; Ranghetti, Pamela; Ponzoni, Maurilio; Leone, Gabriella; De Pascali, Valeria; Pecciarini, Lorenza; Ghia, Paolo; Caligaris-Cappio, Federico; Scielzo, Cristina.
Afiliação
  • Agathangelidis A; IRCCS San Raffaele Scientific Institute, Division of Experimental Oncology, Unit of Lymphoid Malignancies, Milano, Italy; IRCCS San Raffaele Scientific Institute, Division of Experimental Oncology, Unit of B Cell Neoplasia, Milano, Italy.
  • Scarfò L; Università Vita-Salute San Raffaele, Milano, Italy; IRCCS San Raffaele Scientific Institute, Division of Experimental Oncology, Unit of B Cell Neoplasia, Milano, Italy; IRCCS San Raffaele Scientific Institute, Lymphoma Unit, Department of Onco-Hematology, Milan, Italy.
  • Barbaglio F; IRCCS San Raffaele Scientific Institute, Division of Experimental Oncology, Unit of Lymphoid Malignancies, Milano, Italy.
  • Apollonio B; IRCCS San Raffaele Scientific Institute, Division of Experimental Oncology, Unit of Lymphoid Malignancies, Milano, Italy.
  • Bertilaccio MT; IRCCS San Raffaele Scientific Institute, Division of Experimental Oncology, Unit of Lymphoid Malignancies, Milano, Italy; Università Vita-Salute San Raffaele, Milano, Italy.
  • Ranghetti P; IRCCS San Raffaele Scientific Institute, Division of Experimental Oncology, Unit of Lymphoid Malignancies, Milano, Italy.
  • Ponzoni M; IRCCS San Raffaele Scientific Institute, Lymphoma Unit, Department of Onco-Hematology, Milan, Italy; IRCCS San Raffaele Scientific Institute, Pathology Unit, Milan, Italy.
  • Leone G; IRCCS San Raffaele Scientific Institute, Lymphoma Unit, Department of Onco-Hematology, Milan, Italy; IRCCS San Raffaele Scientific Institute, Pathology Unit, Milan, Italy.
  • De Pascali V; IRCCS San Raffaele Scientific Institute, Pathology Unit, Milan, Italy.
  • Pecciarini L; IRCCS San Raffaele Scientific Institute, Pathology Unit, Milan, Italy.
  • Ghia P; Università Vita-Salute San Raffaele, Milano, Italy; IRCCS San Raffaele Scientific Institute, Division of Experimental Oncology, Unit of B Cell Neoplasia, Milano, Italy; IRCCS San Raffaele Scientific Institute, Lymphoma Unit, Department of Onco-Hematology, Milan, Italy.
  • Caligaris-Cappio F; IRCCS San Raffaele Scientific Institute, Division of Experimental Oncology, Unit of Lymphoid Malignancies, Milano, Italy; Università Vita-Salute San Raffaele, Milano, Italy; IRCCS San Raffaele Scientific Institute, Lymphoma Unit, Department of Onco-Hematology, Milan, Italy.
  • Scielzo C; IRCCS San Raffaele Scientific Institute, Division of Experimental Oncology, Unit of Lymphoid Malignancies, Milano, Italy; Università Vita-Salute San Raffaele, Milano, Italy.
PLoS One ; 10(6): e0130195, 2015.
Article em En | MEDLINE | ID: mdl-26110819
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Antígenos CD5 Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Antígenos CD5 Idioma: En Ano de publicação: 2015 Tipo de documento: Article